dc.contributor.author | Sheppard, EC | |
dc.contributor.author | Morrish, RB | |
dc.contributor.author | Dillon, MJ | |
dc.contributor.author | Leyland, R | |
dc.contributor.author | Chahwan, R | |
dc.date.accessioned | 2018-03-15T16:19:44Z | |
dc.date.issued | 2018-02-26 | |
dc.description.abstract | Epigenetic modifications, such as histone modifications, DNA methylation status, and non-coding RNAs (ncRNA), all contribute to antibody maturation during somatic hypermutation (SHM) and class-switch recombination (CSR). Histone modifications alter the chromatin landscape and, together with DNA primary and tertiary structures, they help recruit Activation-Induced Cytidine Deaminase (AID) to the immunoglobulin (Ig) locus. AID is a potent DNA mutator, which catalyzes cytosine-to-uracil deamination on single-stranded DNA to create U:G mismatches. It has been shown that alternate chromatin modifications, in concert with ncRNAs and potentially DNA methylation, regulate AID recruitment and stabilize DNA repair factors. We, hereby, assess the combination of these distinct modifications and discuss how they contribute to initiating differential DNA repair pathways at the Ig locus, which ultimately leads to enhanced antibody-antigen binding affinity (SHM) or antibody isotype switching (CSR). We will also highlight how misregulation of epigenomic regulation during DNA repair can compromise antibody development and lead to a number of immunological syndromes and cancer. | en_GB |
dc.description.sponsorship | The authors wish to thank
Matthew Scharff, Shanzhi Wang, Sergio Roa, and Emma Knight
for their insight, and funding for RC from the Biotechnology
and Biological Research Council [BB/N017773/1], Royal Society
[IE150290], and Academy of Medical Sciences Springboard
Award. ECS and RBM are funded by Ph.D. studentships from
the Biotechnology and Biological Research Council-funded
South West Doctoral Training Partnership [BB/J014400/1] and
the Engineering and Physical Sciences Research Council-funded
Doctoral Training Partnership [EP/M506527/1], respectively. | en_GB |
dc.identifier.citation | Vol. 9, article 355 | en_GB |
dc.identifier.doi | 10.3389/fimmu.2018.00355 | |
dc.identifier.uri | http://hdl.handle.net/10871/32128 | |
dc.language.iso | en | en_GB |
dc.publisher | Frontiers Media | en_GB |
dc.rights | Copyright © 2018 Sheppard, Morrish, Dillon, Leyland and Chahwan. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms. | en_GB |
dc.subject | epigenetic modifications | en_GB |
dc.subject | epigenomics | en_GB |
dc.subject | epigenetics | en_GB |
dc.subject | antibody diversity | en_GB |
dc.subject | cytosine deamination | en_GB |
dc.subject | somatic hypermutation | en_GB |
dc.subject | class-switch recombination | en_GB |
dc.subject | B cell maturation | en_GB |
dc.title | Epigenomic modifications mediating antibody maturation | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2018-03-15T16:19:44Z | |
dc.identifier.issn | 1664-3224 | |
dc.description | This is the final version of the article. Available from the publisher via the DOI in this record. | en_GB |
dc.identifier.journal | Frontiers in Immunology | en_GB |